CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+4.3%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$4.96B
AUM Growth
+$180M
(+3.8%)
Cap. Flow
+$12.8M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
16.47%
Holding
684
New
65
Increased
262
Reduced
255
Closed
50
Top Buys
| 1 |
Amgen
AMGN
|
$53.9M |
| 2 |
Johnson & Johnson
JNJ
|
$42.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$28.2M |
| 4 |
PepsiCo
PEP
|
$27.2M |
| 5 |
Mastercard
MA
|
$24.5M |
Top Sells
| 1 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
$29.3M |
| 2 |
ADT
ADT CORP
ADT
|
$26.4M |
| 3 |
First Solar
FSLR
|
$24.8M |
| 4 |
Cigna
CI
|
$23.7M |
| 5 |
AET
Aetna Inc
AET
|
$21.7M |
Sector Composition
| 1 | Healthcare | 27.7% |
| 2 | Financials | 13.24% |
| 3 | Technology | 10.61% |
| 4 | Industrials | 7.93% |
| 5 | Consumer Discretionary | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Nektar Therapeutics
NKTR
$764M
| $3.52M | 0.07% |
21,333
+1,000
| +5% | +$165K |
|
|
EIGR
302
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.51M | 0.07% |
411
+55
| +15% | +$469K |
|
303
Walmart
WMT
$801B
| $3.5M | 0.07% |
127,701
-169,626
| -57% | -$4.65M |
|
|
ACHN
304
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $3.5M | 0.07% |
355,000
+50,000
| +16% | +$493K |
|
|
DRNA
305
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $3.49M | 0.07% |
145,000
+35,000
| +32% | +$841K |
|
306
TechnipFMC
FTI
$16B
| $3.46M | 0.07% |
125,620
+112,555
| +862% | +$3.1M |
|
|
PRE
307
DELISTED
PARTNERRE LTD
PRE
| $3.43M | 0.07% |
29,995
-33,454
| -53% | -$3.83M |
|
|
GHDX
308
DELISTED
Genomic Health, Inc.
GHDX
| $3.39M | 0.07% |
111,000
-9,000
| -8% | -$275K |
|
309
The Mosaic Company
MOS
$10.3B
| $3.38M | 0.07% |
73,434
+68,347
| +1,344% | +$3.15M |
|
|
MRTX
310
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.34M | 0.07% |
114,000
+44,000
| +63% | +$1.29M |
|
311
Hasbro
HAS
$11.2B
| $3.34M | 0.07% |
+52,739
| New | +$3.34M |
|
312
Entergy
ETR
$39.2B
| $3.29M | 0.07% |
84,764
+76,802
| +965% | +$2.98M |
|
313
Baxter International
BAX
$12.5B
| $3.26M | 0.07% |
87,600
-9,574
| -10% | -$356K |
|
|
IMGN
314
DELISTED
Immunogen Inc
IMGN
| $3.22M | 0.06% |
360,000
-125,000
| -26% | -$1.12M |
|
|
MDCO
315
DELISTED
Medicines Co
MDCO
| $3.22M | 0.06% |
115,000
+40,000
| +53% | +$1.12M |
|
316
Cencora
COR
$56.7B
| $3.21M | 0.06% |
28,220
-2,274
| -7% | -$259K |
|
|
AGEN
317
Agenus
AGEN
$138M
| $3.18M | 0.06% |
31,589
+19,361
| +158% | +$1.95M |
|
318
Arbutus Biopharma
ABUS
$805M
| $3.18M | 0.06% |
+182,000
| New | +$3.18M |
|
319
Canadian National Railway
CNI
$60.3B
| $3.18M | 0.06% |
47,442
-5,090
| -10% | -$341K |
|
320
Banco Bradesco
BBD
$33.6B
| $3.15M | 0.06% |
721,947
-76,531
| -10% | -$334K |
|
|
CALA
321
DELISTED
Calithera Biosciences, Inc
CALA
| $3.12M | 0.06% |
+9,500
| New | +$3.12M |
|
|
TWC
322
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $3.1M | 0.06% |
20,691
-7,720
| -27% | -$1.16M |
|
|
OMED
323
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $3.09M | 0.06% |
120,000
+30,000
| +33% | +$774K |
|
|
MON
324
DELISTED
Monsanto Co
MON
| $3.09M | 0.06% |
27,446
-16,976
| -38% | -$1.91M |
|
325
Unum
UNM
$12.6B
| $3.03M | 0.06% |
89,794
-282,968
| -76% | -$9.55M |
|